Friday, January 18, 2008

Tobacco To Be Used In a Vaccine for Amoeobiasis

For many people, tobacco represents a death sentence due to inflicting nicotine addiction, lung cancer, etc. But for the people of Central and South America at risk for amoebiasis, tobacco could instead be a lifesaver.

The researchers at the University of Central Florida have been able to produce a protein against amoebiasis, a disease caused by the parasite entamoeba hisolytica, from genetically engineered tobacco plants.

According to the researchers, the antigen derived from the genetically modified tobacco plant was found to be more efficient than the other genetically engineered plants.Further development in this method could pave way for low cost oral vaccines.

The National Institute of Science and Media is at the forefront when it comes to the information on the advances made in the field of science and biotechnology.

Joel Ball, the lead author on various study resources published on biotechnology and science under the NISM name is an established author in scientific and publishing circles.

No comments: